Emily A. Berthiaume
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emily A. Berthiaume has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Chia Soo
Division of Plastic and Reconstructive Surgery, Department of Orthopaedic Surgery, Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA
7 shared publications - Kang Ting
Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, UCLA and Orthopaedic Hospital, University of California, Los Angeles, California, 90095, USA
6 shared publications - Chenshuang Li
Department of Orthodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
5 shared publications Wenlu Jiang
Division of Growth and Development, School of Dentistry, and
4 shared publicationsXinli Zhang
Dental and Craniofacial Research Institute and Section of Orthodontics, School of Dentistry, University of California, Los Angeles, Los Angeles, California
4 shared publications- Zhong Zheng
Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
4 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by SAGE Publications in Global Spine Journal
The Impact of Hip Osteoarthritis on Patient Reported Outcomes Following Lumbar Fusion
Study Design: Retrospective Cohort Study. Objectives: With an aging population, the burden of concomitant joint disease continues to rise. The effects of hip OA on lumbar fusion outcomes are underexplored. Therefore, this study aimed to: (1) describe demographic differences between Osteoarthritis (OA) patients and those without OA; (2) assess perioperative differences; and (3) compare patient-reported outcome measures (PROMs). Methods: A retrospective review of a single academic tertiary center was performed (2016-2025). Patients undergoing lumbar fusion with isolated hip OA or no diagnosis of OA, and 12-month ODI scores were included. Patients with prior arthroplasty were excluded. Kellgren-Lawrence scores were collected through chart review or graded on x-ray when missing. Patients were stratified based on the presence of Hip OA. Bivariate comparison was performed as appropriate. Multivariable regressions were performed to identify independent predictors of PROMs. Results: A total of 271 patients were included (No OA: 229; OA: 42). There were significant differences between groups regarding age (71.8 versus 60.2 years, P P =0.025), and smoking status ( P 0.05). Conclusions: These findings suggest that concomitant hip OA may not independently impact postoperative recovery and should not be considered a contraindication to lumbar fusion.
- 14 October 2026
- Published by SAGE Publications in Global Spine Journal
Open AccessThe Impact of Hip Osteoarthritis on Patient Reported Outcomes Following Lumbar Fusion
Study Design: Retrospective Cohort Study. Objectives: With an aging population, the burden of concomitant joint disease continues to rise. The effects of hip OA on lumbar fusion outcomes are underexplored. Therefore, this study aimed to: (1) describe demographic differences between Osteoarthritis (OA) patients and those without OA; (2) assess perioperative differences; and (3) compare patient-reported outcome measures (PROMs). Methods: A retrospective review of a single academic tertiary center was performed (2016-2025). Patients undergoing lumbar fusion with isolated hip OA or no diagnosis of OA, and 12-month ODI scores were included. Patients with prior arthroplasty were excluded. Kellgren-Lawrence scores were collected through chart review or graded on x-ray when missing. Patients were stratified based on the presence of Hip OA. Bivariate comparison was performed as appropriate. Multivariable regressions were performed to identify independent predictors of PROMs. Results: A total of 271 patients were included (No OA: 229; OA: 42). There were significant differences between groups regarding age (71.8 versus 60.2 years, P P =0.025), and smoking status ( P 0.05). Conclusions: These findings suggest that concomitant hip OA may not independently impact postoperative recovery and should not be considered a contraindication to lumbar fusion.
- Open Access
- 30 June 2023
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 17 (3) , 518-528
Effect of Interbody Composition on the Development of Pseudarthrosis Following Anterior Cervical Discectomy and Fusion
Study Design: Retrospective cohort study.Purpose: To determine if polyetheretherketone (PEEK) or titanium alloy cages increase the rate of pseudarthrosis development or revision surgery rate compared with structural allograft following anterior cervical discectomy and fusion (ACDF) and identify if the cage type results in differences in patient-reported outcome measures (PROMs) versus structural allograft.Overview of Literature: PEEK and titanium alloy cages have become popular options for ACDF intervertebral spacers. However, while data is beginning to emerge on how cage types affect arthrodesis rates, the effect of their composition on PROMs is less clear.Methods: All patients aged >18 years who underwent primary one- to four-level ACDF at a single institution were retrospectively identified. Propensity matching was performed to compare patients’ PEEK or titanium alloy cages with structural allograft. Multivariate logistic regression analysis was performed to measure the effect of interbody spacer composition on the likelihood of pseudarthrosis development.Results: Of the 502 patients who received structural allograft and had 1-year postoperative dynamic radiographs, 96 patients were propensity matched to 32 patients who received a PEEK cage, and 162 patients were propensity matched to 54 patients who received a titanium alloy cage. Multivariate logistic regression analysis identified that PEEK cage implants (odds ratio [OR], 3.34; p =0.007) predicted pseudarthrosis development compared with structural allograft implantation. Titanium alloy cage (OR, 1.64; p =0.156) implantation was not predictive of pseudarthrosis. One-year postoperative PROMs were not significantly different between patients who received PEEK or titanium alloy cages and those who received structural allograft (all p >0.05).Conclusions: Compared with structural allograft, receiving a PEEK cage increased the risk of pseudarthrosis development following ACDF, whereas receiving a titanium alloy cage had no significant effect on pseudarthrosis development. One-year postoperative patient-reported outcomes were similar between patients who received structural allograft, PEEK, and titanium alloy interbody spacers.
- 30 June 2023
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 17 (3) , 518-528
Open AccessEffect of Interbody Composition on the Development of Pseudarthrosis Following Anterior Cervical Discectomy and Fusion
Study Design: Retrospective cohort study.Purpose: To determine if polyetheretherketone (PEEK) or titanium alloy cages increase the rate of pseudarthrosis development or revision surgery rate compared with structural allograft following anterior cervical discectomy and fusion (ACDF) and identify if the cage type results in differences in patient-reported outcome measures (PROMs) versus structural allograft.Overview of Literature: PEEK and titanium alloy cages have become popular options for ACDF intervertebral spacers. However, while data is beginning to emerge on how cage types affect arthrodesis rates, the effect of their composition on PROMs is less clear.Methods: All patients aged >18 years who underwent primary one- to four-level ACDF at a single institution were retrospectively identified. Propensity matching was performed to compare patients’ PEEK or titanium alloy cages with structural allograft. Multivariate logistic regression analysis was performed to measure the effect of interbody spacer composition on the likelihood of pseudarthrosis development.Results: Of the 502 patients who received structural allograft and had 1-year postoperative dynamic radiographs, 96 patients were propensity matched to 32 patients who received a PEEK cage, and 162 patients were propensity matched to 54 patients who received a titanium alloy cage. Multivariate logistic regression analysis identified that PEEK cage implants (odds ratio [OR], 3.34; p =0.007) predicted pseudarthrosis development compared with structural allograft implantation. Titanium alloy cage (OR, 1.64; p =0.156) implantation was not predictive of pseudarthrosis. One-year postoperative PROMs were not significantly different between patients who received PEEK or titanium alloy cages and those who received structural allograft (all p >0.05).Conclusions: Compared with structural allograft, receiving a PEEK cage increased the risk of pseudarthrosis development following ACDF, whereas receiving a titanium alloy cage had no significant effect on pseudarthrosis development. One-year postoperative patient-reported outcomes were similar between patients who received structural allograft, PEEK, and titanium alloy interbody spacers.
- 1 January 2020
- Published by Elsevier in Biomaterials
- Vol. 226, 119541
Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drug
- 1 January 2020
- Published by Elsevier in Biomaterials
- Vol. 226, 119541
Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drug
- 1 October 2019
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 84 (2) , 222-231
Evaluating Current Scar Assessment Methods
Current scar surveys have included many questions to evaluate the physical characteristics of scars, with some expanding to include physical implications and patient opinions. This review provides an analysis of frequently used scar assessment methods to date and highlights potential areas for improvement. We build the case that a new assessment tool is necessary, specifically one that centers on psychosocial consequences of scars that influence patient decision making for treatment, allowing physicians to individualize treatment conversations with patients. We postulate that survey techniques used in consumer product marketing, such as choice-based conjoint analysis, may be effective in determining the factors strongly influencing patient decision making and spending in scar treatment; therefore, more research in this area is warranted. By incorporating these psychosocial and economic considerations driving scar treatment decisions, future scar assessment tools may accomplish much more than characterizing/documenting the clinical aspects of scars. Rather, these patient-centered, holistic tools may be implemented by plastic surgeons and other clinicians specifically to provide patients with personalized treatment options that maximize long-term patient satisfaction.
- 1 October 2019
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 84 (2) , 222-231
Evaluating Current Scar Assessment Methods
Current scar surveys have included many questions to evaluate the physical characteristics of scars, with some expanding to include physical implications and patient opinions. This review provides an analysis of frequently used scar assessment methods to date and highlights potential areas for improvement. We build the case that a new assessment tool is necessary, specifically one that centers on psychosocial consequences of scars that influence patient decision making for treatment, allowing physicians to individualize treatment conversations with patients. We postulate that survey techniques used in consumer product marketing, such as choice-based conjoint analysis, may be effective in determining the factors strongly influencing patient decision making and spending in scar treatment; therefore, more research in this area is warranted. By incorporating these psychosocial and economic considerations driving scar treatment decisions, future scar assessment tools may accomplish much more than characterizing/documenting the clinical aspects of scars. Rather, these patient-centered, holistic tools may be implemented by plastic surgeons and other clinicians specifically to provide patients with personalized treatment options that maximize long-term patient satisfaction.
- 15 July 2019
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 129 (8) , 3236-3251
CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells
Tumorigenicity is a well-documented risk to overcome for pluripotent or multipotent cell applications in regenerative medicine. To address the emerging demand for safe cell sources in tissue regeneration, we established a novel, protein-based reprogramming method that does not require genome integration or oncogene activation to yield multipotent fibromodulin (FMOD)-reprogrammed (FReP) cells from dermal fibroblasts. When compared with induced pluripotent stem cells (iPSCs), FReP cells exhibited a superior capability for bone and skeletal muscle regeneration with markedly less tumorigenic risk. Moreover, we showed that the decreased tumorigenicity of FReP cells was directly related to an upregulation of cyclin-dependent kinase inhibitor 2B (CDKN2B) expression during the FMOD reprogramming process. Indeed, sustained suppression of CDKN2B resulted in tumorigenic, pluripotent FReP cells that formed teratomas in vivo that were indistinguishable from iPSC-derived teratomas. These results highlight the pivotal role of CDKN2B in cell fate determination and tumorigenic regulation and reveal an alternative pluripotent/multipotent cell reprogramming strategy that solely uses FMOD protein.
- 15 July 2019
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 129 (8) , 3236-3251
CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells
Tumorigenicity is a well-documented risk to overcome for pluripotent or multipotent cell applications in regenerative medicine. To address the emerging demand for safe cell sources in tissue regeneration, we established a novel, protein-based reprogramming method that does not require genome integration or oncogene activation to yield multipotent fibromodulin (FMOD)-reprogrammed (FReP) cells from dermal fibroblasts. When compared with induced pluripotent stem cells (iPSCs), FReP cells exhibited a superior capability for bone and skeletal muscle regeneration with markedly less tumorigenic risk. Moreover, we showed that the decreased tumorigenicity of FReP cells was directly related to an upregulation of cyclin-dependent kinase inhibitor 2B (CDKN2B) expression during the FMOD reprogramming process. Indeed, sustained suppression of CDKN2B resulted in tumorigenic, pluripotent FReP cells that formed teratomas in vivo that were indistinguishable from iPSC-derived teratomas. These results highlight the pivotal role of CDKN2B in cell fate determination and tumorigenic regulation and reveal an alternative pluripotent/multipotent cell reprogramming strategy that solely uses FMOD protein.
- 1 March 2019
- Published by Elsevier in The American Journal of Pathology
- Vol. 189 (3) , 648-664
Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2–Induced Critical-Size Bone Defect Repair
- 1 March 2019
- Published by Elsevier in The American Journal of Pathology
- Vol. 189 (3) , 648-664
Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2–Induced Critical-Size Bone Defect Repair
- 1 January 2019
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 9 (3) , e0211
Surgical Repair of an Avulsed Distal Flexor Carpi Radialis Tendon in a Boxer
Case: A 25-year-old professional boxer presented with a right distal flexor carpi radialis (FCR) tendon avulsion after sustaining an injury while boxing. The avulsion was identified and confirmed with magnetic resonance imaging, and the tendon was successfully reinserted into the trapezium. The patient returned to professional boxing 10 months later without complication. Conclusions: Distal FCR tendon avulsions are rare. Occasionally, this tendon can avulse after an application of excessive force. For some patients, unrepaired distal FCR tendon avulsions may prevent competitive performance. In this case, the tendon was reattached to the trapezium to aid wrist motion and stability, which are essential for professional boxing.
- 1 January 2019
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 9 (3) , e0211
Surgical Repair of an Avulsed Distal Flexor Carpi Radialis Tendon in a Boxer
Case: A 25-year-old professional boxer presented with a right distal flexor carpi radialis (FCR) tendon avulsion after sustaining an injury while boxing. The avulsion was identified and confirmed with magnetic resonance imaging, and the tendon was successfully reinserted into the trapezium. The patient returned to professional boxing 10 months later without complication. Conclusions: Distal FCR tendon avulsions are rare. Occasionally, this tendon can avulse after an application of excessive force. For some patients, unrepaired distal FCR tendon avulsions may prevent competitive performance. In this case, the tendon was reattached to the trapezium to aid wrist motion and stability, which are essential for professional boxing.
- Open Access
- 15 June 2018
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 33 (10) , 1813-1825
Neurexin Superfamily Cell Membrane Receptor Contactin-Associated Protein Like-4 (Cntnap4) Is Involved in Neural EGFL-Like 1 (Nell-1)-Responsive Osteogenesis
Contactin‐associated protein‐like 4 (Cntnap4) is a member of the neurexin superfamily of transmembrane molecules that have critical functions in neuronal cell communication. Cntnap4 knockout mice display decreased presynaptic gamma‐aminobutyric acid (GABA) and increased dopamine release that is associated with severe, highly penetrant, repetitive, and perseverative movements commonly found in human autism spectrum disorder patients. However, no known function of Cntnap4 has been revealed besides the nervous system. Meanwhile, secretory protein neural EGFL‐like 1 (Nell‐1) is known to exert potent osteogenic effects in multiple small and large animal models without the off‐target effects commonly found with bone morphogenetic protein 2. In this study, while searching for a Nell‐1‐specific cell surface receptor during osteogenesis, we identified and validated a ligand/receptor‐like interaction between Nell‐1 and Cntnap4 by demonstrating: 1) Nell‐1 and Cntnap4 colocalization on the surface of osteogenic‐committed cells; 2) high‐affinity interaction between Nell‐1 and Cntnap4; 3) abrogation of Nell‐1‐responsive Wnt and MAPK signaling transduction, as well as osteogenic effects, via Cntnap4 knockdown; and 4) replication of calvarial cleidocranial dysplasias‐like defects observed in Nell‐1‐deficient mice in Wnt1‐Cre‐mediated Cntnap4‐knockout transgenic mice. In aggregate, these findings indicate that Cntnap4 plays a critical role in Nell‐1‐responsive osteogenesis. Further, this is the first functional annotation for Cntnap4 in the musculoskeletal system. Intriguingly, Nell‐1 and Cntnap4 also colocalize on the surface of human hippocampal interneurons, implicating Nell‐1 as a potential novel ligand for Cntnap4 in the nervous system. This unexpected characterization of the ligand/receptor‐like interaction between Nell‐1 and Cntnap4 indicates a novel biological functional axis for Nell‐1 and Cntnap4 in osteogenesis and, potentially, in neural development and function. © 2018 American Society for Bone and Mineral Research.
- 15 June 2018
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 33 (10) , 1813-1825
Open AccessNeurexin Superfamily Cell Membrane Receptor Contactin-Associated Protein Like-4 (Cntnap4) Is Involved in Neural EGFL-Like 1 (Nell-1)-Responsive Osteogenesis
Contactin‐associated protein‐like 4 (Cntnap4) is a member of the neurexin superfamily of transmembrane molecules that have critical functions in neuronal cell communication. Cntnap4 knockout mice display decreased presynaptic gamma‐aminobutyric acid (GABA) and increased dopamine release that is associated with severe, highly penetrant, repetitive, and perseverative movements commonly found in human autism spectrum disorder patients. However, no known function of Cntnap4 has been revealed besides the nervous system. Meanwhile, secretory protein neural EGFL‐like 1 (Nell‐1) is known to exert potent osteogenic effects in multiple small and large animal models without the off‐target effects commonly found with bone morphogenetic protein 2. In this study, while searching for a Nell‐1‐specific cell surface receptor during osteogenesis, we identified and validated a ligand/receptor‐like interaction between Nell‐1 and Cntnap4 by demonstrating: 1) Nell‐1 and Cntnap4 colocalization on the surface of osteogenic‐committed cells; 2) high‐affinity interaction between Nell‐1 and Cntnap4; 3) abrogation of Nell‐1‐responsive Wnt and MAPK signaling transduction, as well as osteogenic effects, via Cntnap4 knockdown; and 4) replication of calvarial cleidocranial dysplasias‐like defects observed in Nell‐1‐deficient mice in Wnt1‐Cre‐mediated Cntnap4‐knockout transgenic mice. In aggregate, these findings indicate that Cntnap4 plays a critical role in Nell‐1‐responsive osteogenesis. Further, this is the first functional annotation for Cntnap4 in the musculoskeletal system. Intriguingly, Nell‐1 and Cntnap4 also colocalize on the surface of human hippocampal interneurons, implicating Nell‐1 as a potential novel ligand for Cntnap4 in the nervous system. This unexpected characterization of the ligand/receptor‐like interaction between Nell‐1 and Cntnap4 indicates a novel biological functional axis for Nell‐1 and Cntnap4 in osteogenesis and, potentially, in neural development and function. © 2018 American Society for Bone and Mineral Research.